Global Clot Management Devices Market (2016-2022)

  • ID: 4060450
  • Report
  • Region: Global
  • 160 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Cook Medical Inc.
  • Johnson & Johnson
  • Lemaitre Vascular, Inc.
  • Medtronic Plc
  • Straub Medical AG
  • Teleflex Inc.
  • MORE
Blood Clotting also known as coagulation is the body’s response to an injury to prevent bleeding. It prevents excessive bleeding when the blood vessels are injured. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Blood Clot forms in one or more veins located deep inside a human body would lead to Deep Vein Thrombosis (DVT) and could damage an organ completely. Clot Management devices are used for the treatment of coronary thrombosis, periphery artery, arteriovenous, neurovascular and DVT. As per the World Health Organisation (WHO), more than 17 million people die annually from cardiovascular diseases. The main reason for cardiovascular diseases are increasing consumption of tobacco products, physical inactivity, changes in diet plans, air pollution and work pressure.

Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters. Based on End user Type, the market is segmented into Hospitals and Diagnostic Centres.

Based on region, Clot Management Devices market is segmented into North America (US, Canada, Mexico and Rest of North America), Europe (Germany, UK, France, Russia, Spain, Italy and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia-Pacific) and Latin America, and Middle East & Africa. North America remained the dominant region in the global Clot Management Devices market in 2015. Asia-Pacific would witness promising CAGR during the forecast period (2016-2022).

The report covers the analysis of key stake holders of the Clot Management Devices market. Key companies profiled in the report include Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cook Medical Inc.
  • Johnson & Johnson
  • Lemaitre Vascular, Inc.
  • Medtronic Plc
  • Straub Medical AG
  • Teleflex Inc.
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Clot Management Devices Market, by Product Type
1.4.2 Global Clot Management Devices Market, by End User
1.4.3 Global Clot Management Devices Market, by Geography
1.5 Methodology for the research

2. Executive Summary

3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints

4. Global Clot Management Market by Product
4.1 Introduction
4.2 Global Clot Management Market by Product
4.2.1 Global Clot Management for Percutaneous Thrombectomy Devices Market by Region
4.2.2 Global Clot Management for Embolectomy Balloon Catheters Market by Region
4.2.3 Global Clot Management for Catheter-Directed Thrombolysis (CDT) devices Market by Region
4.2.4 Global Clot Management for Neurovascular Embolectomy Devices Market by Region
4.2.5 Global Clot Management for Other Product Market by Region

5. Global Clot Management Market by End User
5.1 Introduction
5.1.1 Global Hospitals Clot Management Market by Region
5.1.2 Global Diagnostic Centers Clot Management Market by Region

6. Global Clot Management Market by Region
6.1 Introduction
6.2 North America Clot Management Market
6.2.1 North America Clot Management Market by Product
6.2.1.1 North America Clot Management for Percutaneous Thrombectomy Devices Market by Country
6.2.1.2 North America Clot Management for Embolectomy Balloon Catheters Market by Country
6.2.1.3 North America Clot Management for Catheter-Directed Thrombolysis (CDT) devices Market by Country
6.2.1.4 North America Clot Management for Neurovascular Embolectomy Devices Market by Country
6.2.1.5 North America Clot Management for Other Product Market by Country
6.2.2 North America Clot Management Market by End User
6.2.2.1 North America Hospitals Clot Management Market by Country
6.2.2.2 North America Diagnostic Centers Clot Management Market by Country
6.2.3 North America Clot Management Market by Country
6.2.3.1 US Clot Management Market
6.2.3.1.1 US Clot Management Market by Product
6.2.3.1.2 US Clot Management Market by End User
6.2.3.2 Canada Clot Management Market
6.2.3.2.1 Canada Clot Management Market by Product
6.2.3.2.2 Canada Clot Management Market by End User
6.2.3.3 Mexico Clot Management Market
6.2.3.3.1 Mexico Clot Management Market by Product
6.2.3.3.2 Mexico Clot Management Market by End User
6.2.3.4 Rest of North America Clot Management Market
6.2.3.4.1 Rest of North America Clot Management Market by Product
6.2.3.4.2 Rest of North America Clot Management Market by End User
6.3 Europe Clot Management Market
6.3.1 Europe Clot Management Market by Product
6.3.1.1 Europe Clot Management for Percutaneous Thrombectomy Devices Market by Country
6.3.1.2 Europe Clot Management for Embolectomy Balloon Catheters Market by Country
6.3.1.3 Europe Clot Management for Catheter-Directed Thrombolysis (CDT) devices Market by Country
6.3.1.4 Europe Clot Management for Neurovascular Embolectomy Devices Market by Country
6.3.1.5 Europe Clot Management for Other Product Market by Country
6.3.2 Europe Clot Management Market by End User
6.3.2.1 Europe Hospitals Clot Management Market by Country
6.3.2.2 Europe Diagnostic Centers Clot Management Market by Country
6.3.3 Europe Clot Management Market by Country
6.3.3.1 Germany Clot Management Market
6.3.3.1.1 Germany Clot Management Market by Product
6.3.3.1.2 Germany Clot Management Market by End User
6.3.3.2 UK Clot Management Market
6.3.3.2.1 UK Clot Management Market by Product
6.3.3.2.2 UK Clot Management Market by End User
6.3.3.3 France Clot Management Market
6.3.3.3.1 France Clot Management Market by Product
6.3.3.3.2 France Clot Management Market by End User
6.3.3.4 Russia Clot Management Market
6.3.3.4.1 Russia Clot Management Market by Product
6.3.3.4.2 Russia Clot Management Market by End User
6.3.3.5 Spain Clot Management Market
6.3.3.5.1 Spain Clot Management Market by Product
6.3.3.5.2 Spain Clot Management Market by End User
6.3.3.6 Italy Clot Management Market
6.3.3.6.1 Italy Clot Management Market by Product
6.3.3.6.2 Italy Clot Management Market by End User
6.3.3.7 Rest of Europe Clot Management Market
6.3.3.7.1 Rest of Europe Clot Management Market by Product
6.3.3.7.2 Rest of Europe Clot Management Market by End User
6.4 Asia-Pacific Clot Management Market
6.4.1 Asia-Pacific Clot Management Market by Product
6.4.1.1 Asia-Pacific Clot Management for Percutaneous Thrombectomy Devices Market by Country
6.4.1.2 Asia-Pacific Clot Management for Embolectomy Balloon Catheters Market by Country
6.4.1.3 Asia-Pacific Clot Management for Catheter-Directed Thrombolysis (CDT) devices Market by Country
6.4.1.4 Asia-Pacific Clot Management for Neurovascular Embolectomy Devices Market by Country
6.4.1.5 Asia-Pacific Clot Management for Other Product Market by Country
6.4.2 Asia-Pacific Clot Management Market by End User
6.4.2.1 Asia-Pacific Hospitals Clot Management Market by Country
6.4.2.2 Asia-Pacific Diagnostic Centers Clot Management Market by Country
6.4.3 Asia-Pacific Clot Management Market by Country
6.4.3.1 China Clot Management Market
6.4.3.1.1 China Clot Management Market by Product
6.4.3.1.2 China Clot Management Market by End User
6.4.3.2 Japan Clot Management Market
6.4.3.2.1 Japan Clot Management Market by Product
6.4.3.2.2 Japan Clot Management Market by End User
6.4.3.3 India Clot Management Market
6.4.3.3.1 India Clot Management Market by Product
6.4.3.3.2 India Clot Management Market by End User
6.4.3.4 South Korea Clot Management Market
6.4.3.4.1 South Korea Clot Management Market by Product
6.4.3.4.2 South Korea Clot Management Market by End User
6.4.3.5 Singapore Clot Management Market
6.4.3.5.1 Singapore Clot Management Market by Product
6.4.3.5.2 Singapore Clot Management Market by End User
6.4.3.6 Malaysia Clot Management Market
6.4.3.6.1 Malaysia Clot Management Market by Product
6.4.3.6.2 Malaysia Clot Management Market by End User
6.4.3.7 Rest of Asia-Pacific Clot Management Market
6.4.3.7.1 Rest of Asia-Pacific Clot Management Market by Product
6.4.3.7.2 Rest of Asia-Pacific Clot Management Market by End User
6.5 LAMEA Clot Management Market
6.5.1 LAMEA Clot Management Market by Product
6.5.1.1 LAMEA Clot Management for Percutaneous Thrombectomy Devices Market by Country
6.5.1.2 LAMEA Clot Management for Embolectomy Balloon Catheters Market by Country
6.5.1.3 LAMEA Clot Management for Catheter-Directed Thrombolysis (CDT) devices Market by Country
6.5.1.4 LAMEA Clot Management for Neurovascular Embolectomy Devices Market by Country
6.5.1.5 LAMEA Clot Management for Other Product Market by Country
6.5.2 LAMEA Clot Management Market by End User
6.5.2.1 LAMEA Hospitals Clot Management Market by Country
6.5.2.2 LAMEA Diagnostic Centers Clot Management Market by Country
6.5.3 LAMEA Clot Management Market by Country
6.5.3.1 Brazil Clot Management Market
6.5.3.1.1 Brazil Clot Management Market by Product
6.5.3.1.2 Brazil Clot Management Market by End User
6.5.3.2 Argentina Clot Management Market
6.5.3.2.1 Argentina Clot Management Market by Product
6.5.3.2.2 Argentina Clot Management Market by End User
6.5.3.3 UAE Clot Management Market
6.5.3.3.1 UAE Clot Management Market by Product
6.5.3.3.2 UAE Clot Management Market by End User
6.5.3.4 Saudi Arabia Clot Management Market
6.5.3.4.1 Saudi Arabia Clot Management Market by Product
6.5.3.4.2 Saudi Arabia Clot Management Market by End User
6.5.3.5 South Africa Clot Management Market
6.5.3.5.1 South Africa Clot Management Market by Product
6.5.3.5.2 South Africa Clot Management Market by End User
6.5.3.6 Nigeria Clot Management Market
6.5.3.6.1 Nigeria Clot Management Market by Product
6.5.3.6.2 Nigeria Clot Management Market by End User
6.5.3.7 Rest of LAMEA Clot Management Market
6.5.3.7.1 Rest of LAMEA Clot Management Market by Product
6.5.3.7.2 Rest of LAMEA Clot Management Market by End User

7. Company Profiles
7.1 Teleflex Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Edwards Lifesciences Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Medtronic Plc
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Lemaitre Vascular, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.6 Straub Medical AG
7.6.1 Company Overview
7.7 Cook Medical Inc.
7.7.1 Company Overview
7.8 Johnson & Johnson
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expense
7.8.4 Segmental and Regional Analysis
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Teleflex Inc.
  • Edwards Lifesciences Corporation
  • Medtronic Plc
  • Boston Scientific Corporation
  • Lemaitre Vascular, Inc.
  • Straub Medical AG
  • Cook Medical Inc.
  • Johnson & Johnson
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll